
Clarifi Grants - Part of the Clarifi Group
Clarifi Grants turns technical excellence into clear, fundable narratives — helping startups and research teams secure investor funding.
Part of the Clarifi Group
We bridge the gap between science and storytelling so funders can see your value at a glance.Services include:- Full proposal writing & editing
- Impact & exploitation sections
- Regulatory risk & market strategy inputs
- Grant readiness audits & mock evaluationsWe don’t just polish text — we shape the story funders want to read.

CLARIFI.FI
Our experience spans both regulatory and funding worlds — including hands-on work with Business Finland, R2B projects, and a €50 million Series B raise at Infinite Roots (formerly Mushlabs).
That means we understand how to turn complex technology into credible, investable language.

CLARIFI.FI
- University R2B & Business Finland teams
- Deep-tech and FoodTech startups
- EU Horizon and EIC applicants
- Non-profits and public-health projects seeking grant support

CLARIFI.FI
1. Discovery Call (30 min) – scope project and funding target.2. Draft & Align – we translate technical content into funder-ready structure.3. Review & Refine – mock evaluation and gap feedback.4. Delivery – final version ready for submission.

- Regulatory Fit Statement (for funders carrying out compliance due diligence)
- Letters of Intent / Work Package review
- Pitch Deck alignment for investor follow-up
Need a grant that stands out to reviewers and investors alike?
Let’s craft it together.Get in touch below or at info(at)clarifi.fi
Insights and features on how regulation, innovation, and startup strategy intersect — from MedTech to FoodTech and beyond.Startups don’t just need tech leads: They need an integrator.
Feature for EU-Startups
Read →Confidential by Default? The Transparency Dilemma in Europe’s Novel Foods System.
Feature for Green Queen Media
Read →From Gatekeeping to Guiding: The Case for Collaborative Regulation in Mission-Driven Innovation
White Paper in Collaboration with GCI
Read →Digital Health Meets Red Tape: What Pharma Can Learn from Software as a Medical Device
The role of SaMD in pharma covering regulations, AI/ML risks, compliance, and digital health strategies.
Feature for PharmaNow
Read →Lessons from a €50 million Series B: And why it matters at every startup funding stage
Feature for EU-Startups
Read →What does Gourmey’s regulatory milestone mean for cell-cultivated meat?
Interviewed by FI Global Insights
Read →Why EU Innovators Face Growing Barriers With EU Combination Product Regulation
Interviewed by Medtech Insight
Read →From WHOOP to DiGA: Where the Wellness Line Becomes a Regulatory Minefield
Feature for Test Labs UK Outlook
Read →Guest article: EU novel food delays. Why bureaucracy is choking off food innovation
Feature for AgFunder News
Read →How AI can get your novel food approved faster
Interviewed by FoodNavigator Europe
Read →Apple vs WHOOP: Two Blood Pressure Strategies, Two Very Different Regulatory Journeys
Feature for Test Labs UK Outlook
Read →For interviews, collaborations, or speaking opportunities, contact info(at)clarifi.fi
© 2025 Clarifi OyPart of Clarifi Oy — Regulatory | Strategy | Marketing | Ghostwriting | Grants | Policy & Advocacy | Communication | Career CoachingHelsinki, Finland / Suomi | Y-tunnus 3565244-7This website does not use cookies or analytics tracking.